Kodiak Sciences Inc (KOD)’s stock price range in the last year

While Kodiak Sciences Inc has overperformed by 6.43%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, KOD rose by 13.07%, with highs and lows ranging from $11.60 to $1.92, whereas the simple moving average jumped by 108.67% in the last 200 days.

On August 14, 2025, JP Morgan Upgraded Kodiak Sciences Inc (NASDAQ: KOD) to Neutral. A report published by Jefferies on December 09, 2024, Upgraded its rating to ‘Buy’ for KOD. H.C. Wainwright also rated KOD shares as ‘Neutral’, setting a target price of $3 on the company’s shares in an initiating report dated September 05, 2024. Goldman Initiated an Sell rating on December 11, 2023, and assigned a price target of $2. CapitalOne November 17, 2023d its ‘Equal Weight’ rating to ‘Overweight’ for KOD, as published in its report on November 17, 2023. UBS’s report from July 27, 2023 suggests a price prediction of $4 for KOD shares, giving the stock a ‘Neutral’ rating. JP Morgan also rated the stock as ‘Underweight’.

Analysis of Kodiak Sciences Inc (KOD)

Kodiak Sciences Inc’s future performance can be predicted by a variety of well-rounded types of analysis and research, with equity being one of the most crucial ones. The goal here is to ensure that your current return on equity of -140.33% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 3.48, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

For any stock, average volume can be an extremely valuable indicator of volatility, and KOD is registering an average volume of 474.58K. On a monthly basis, the volatility of the stock is set at 13.11%, whereas on a weekly basis, it is put at 12.63%, with a gain of 40.10% over the past seven days. Furthermore, long-term investors anticipate a median target price of $7.25, showing decline from the present price of $11.25, which can serve as yet another indication of whether KOD is worth investing in or should be passed over.

How Do You Analyze Kodiak Sciences Inc Shares?

Besides checking the fundamentals, you should also know how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 7.83%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 76.94% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

Hot this week

Results from Crinetics Pharmaceuticals Inc (CRNX) show risk

While Crinetics Pharmaceuticals Inc has underperformed by -1.04%, investors...

Was anything negative for Coinbase Global Inc (COIN) stock last session?

While Coinbase Global Inc has underperformed by -5.82%, investors...

Sunopta, Inc STKL’s stock price falss traction on Tuesday

While Sunopta, Inc has underperformed by -0.48%, investors are...

ARKO Corp (ARKO)’s stock chart: A technical perspective

While ARKO Corp has underperformed by -1.20%, investors are...

Neogenomics Inc (NEO)’s stock performance: a year in review

While Neogenomics Inc has overperformed by 1.12%, investors are...

Topics

Results from Crinetics Pharmaceuticals Inc (CRNX) show risk

While Crinetics Pharmaceuticals Inc has underperformed by -1.04%, investors...

Was anything negative for Coinbase Global Inc (COIN) stock last session?

While Coinbase Global Inc has underperformed by -5.82%, investors...

Sunopta, Inc STKL’s stock price falss traction on Tuesday

While Sunopta, Inc has underperformed by -0.48%, investors are...

ARKO Corp (ARKO)’s stock chart: A technical perspective

While ARKO Corp has underperformed by -1.20%, investors are...

Neogenomics Inc (NEO)’s stock performance: a year in review

While Neogenomics Inc has overperformed by 1.12%, investors are...

Innovative Solutions And Support Inc (ISSC)’s stock price in review: A technical analysis

While Innovative Solutions And Support Inc has underperformed by...

Zepp Health Corporation ADR (ZEPP)’s stock decline to 39.18 per share

While Zepp Health Corporation ADR has underperformed by -9.89%,...

BBVA Argentina ADR (BBAR) stock analysis: A comprehensive overview

While BBVA Argentina ADR has underperformed by -7.83%, investors...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.